nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—Ergotamine—ADRA1D—polycystic ovary syndrome	0.0231	0.21	CrCbGaD
Ergoloid mesylate—Bromocriptine—ADRA1D—polycystic ovary syndrome	0.0222	0.202	CrCbGaD
Ergoloid mesylate—Ergotamine—ADRA1B—polycystic ovary syndrome	0.0197	0.179	CrCbGaD
Ergoloid mesylate—Bromocriptine—ADRA1B—polycystic ovary syndrome	0.019	0.173	CrCbGaD
Ergoloid mesylate—Ergotamine—ADRA1A—polycystic ovary syndrome	0.0132	0.12	CrCbGaD
Ergoloid mesylate—Bromocriptine—ADRA1A—polycystic ovary syndrome	0.0128	0.116	CrCbGaD
Ergoloid mesylate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00139	0.00156	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00138	0.00155	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00136	0.00153	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00136	0.00152	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00134	0.0015	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00133	0.00149	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00132	0.00148	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00131	0.00147	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00131	0.00147	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00129	0.00145	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00128	0.00144	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00128	0.00144	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00128	0.00144	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00128	0.00144	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00127	0.00143	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00126	0.00141	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00123	0.00138	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00122	0.00137	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00121	0.00136	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00121	0.00136	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00119	0.00134	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00119	0.00133	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00118	0.00132	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00117	0.00132	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00117	0.00132	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00117	0.00131	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00117	0.00131	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00117	0.00131	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00117	0.00131	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00115	0.00129	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00114	0.00128	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00114	0.00128	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00113	0.00127	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0011	0.00123	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0011	0.00123	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.0011	0.00123	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00107	0.0012	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00107	0.0012	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00106	0.00119	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00105	0.00118	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00103	0.00116	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00103	0.00115	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00103	0.00115	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00102	0.00115	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00102	0.00114	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00101	0.00114	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000995	0.00112	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000994	0.00112	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000984	0.00111	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000975	0.0011	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000971	0.00109	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000969	0.00109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000968	0.00109	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000957	0.00108	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000953	0.00107	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000947	0.00106	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000944	0.00106	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000935	0.00105	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000929	0.00104	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000924	0.00104	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000912	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000909	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000903	0.00101	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000897	0.00101	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000887	0.000997	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000883	0.000992	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00088	0.000989	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00088	0.000989	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000871	0.000978	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000866	0.000973	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000857	0.000963	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000857	0.000963	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000848	0.000953	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000836	0.00094	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000826	0.000928	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000808	0.000907	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000807	0.000906	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000802	0.000901	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000802	0.000901	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000793	0.000891	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00079	0.000887	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000788	0.000886	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000778	0.000874	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000778	0.000874	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000777	0.000873	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000775	0.000871	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000768	0.000863	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000766	0.000861	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000757	0.000851	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000751	0.000844	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000743	0.000835	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000738	0.000829	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000733	0.000824	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00072	0.000809	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000706	0.000793	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000706	0.000793	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000701	0.000788	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000698	0.000784	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000689	0.000774	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000689	0.000774	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000687	0.000771	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000682	0.000766	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000672	0.000755	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000654	0.000734	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000647	0.000727	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000647	0.000727	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000627	0.000705	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000624	0.000701	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000624	0.000701	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000615	0.000691	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000614	0.00069	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00061	0.000685	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000609	0.000684	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000605	0.00068	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00059	0.000663	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000588	0.00066	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000574	0.000645	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000572	0.000642	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FST—polycystic ovary syndrome	0.000559	0.000628	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000557	0.000626	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000556	0.000625	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000552	0.000621	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000546	0.000613	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000533	0.000599	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00052	0.000584	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000517	0.00058	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000516	0.000579	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000511	0.000575	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000507	0.00057	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000505	0.000567	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000503	0.000565	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.0005	0.000561	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000496	0.000557	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000488	0.000548	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000479	0.000539	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000475	0.000534	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000474	0.000532	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000468	0.000526	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000464	0.000521	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000461	0.000517	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000445	0.0005	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000444	0.000499	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000442	0.000497	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000438	0.000492	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000433	0.000487	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	0.000422	0.000474	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00042	0.000472	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000419	0.00047	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000417	0.000469	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000412	0.000463	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000405	0.000455	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000405	0.000455	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000403	0.000453	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000398	0.000447	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000392	0.00044	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00039	0.000438	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000389	0.000437	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000388	0.000435	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000386	0.000434	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000381	0.000428	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000377	0.000424	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000376	0.000423	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000375	0.000421	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000368	0.000414	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000362	0.000407	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00036	0.000405	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00036	0.000405	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000359	0.000403	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000353	0.000397	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000347	0.00039	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000344	0.000386	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000335	0.000377	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000335	0.000377	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000334	0.000375	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000331	0.000371	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00032	0.000359	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00032	0.000359	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000317	0.000356	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000316	0.000355	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000315	0.000354	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000314	0.000353	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000303	0.00034	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.0003	0.000337	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000298	0.000335	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000296	0.000332	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000293	0.000329	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000277	0.000311	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000272	0.000306	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000272	0.000306	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000268	0.000301	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000263	0.000296	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000262	0.000294	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00026	0.000292	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000259	0.000291	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000254	0.000285	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000253	0.000284	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000252	0.000283	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000242	0.000272	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00024	0.000269	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000238	0.000267	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000237	0.000267	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000229	0.000257	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000225	0.000253	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000222	0.000249	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000217	0.000244	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000216	0.000243	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000209	0.000235	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000206	0.000232	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000199	0.000223	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000195	0.000219	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000193	0.000217	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000188	0.000211	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000186	0.000209	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000185	0.000208	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000184	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000179	0.000201	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000179	0.000201	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000178	0.0002	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00017	0.000191	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000167	0.000188	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000164	0.000184	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000164	0.000184	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000159	0.000178	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000153	0.000172	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000147	0.000165	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000146	0.000164	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000145	0.000163	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000141	0.000158	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	0.00014	0.000157	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000137	0.000154	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000137	0.000154	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000135	0.000152	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000135	0.000152	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000135	0.000151	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000128	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000117	0.000131	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000117	0.000131	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000113	0.000128	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000107	0.00012	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000103	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.52e-05	0.000107	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	9.07e-05	0.000102	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.83e-05	9.92e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.6e-05	9.66e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	8.09e-05	9.09e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	8.02e-05	9.01e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.5e-05	7.31e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.41e-05	7.2e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.38e-05	7.16e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	6.11e-05	6.86e-05	CbGpPWpGaD
